Soligenix Inc Share Price OTC Bulletin Board
Equities
US8342232084
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2024 * | 708K 56.06M | Sales 2025 * | 900K 71.21M | Capitalization | 2.7M 213M |
---|---|---|---|---|---|
Net income 2024 * | -8M -633M | Net income 2025 * | -9M -712M | EV / Sales 2024 * | 3.81 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3 x |
P/E ratio 2024 * |
-0.33
x | P/E ratio 2025 * |
-0.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.93% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 31/07/06 | |
Jonathan Guarino
DFI | Director of Finance/CFO | 51 | 10/09/19 |
Richard Straube
CTO | Chief Tech/Sci/R&D Officer | 72 | 05/01/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 31/07/06 | |
Gregg Lapointe
BRD | Director/Board Member | 65 | 28/02/09 |
Robert Rubin
BRD | Director/Board Member | 78 | 30/09/09 |
1st Jan change | Capi. | |
---|---|---|
+16.13% | 122B | |
+19.65% | 115B | |
+21.22% | 26.64B | |
-23.84% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-19.28% | 15.49B | |
+63.81% | 14.83B | |
+1.94% | 13.67B |